Christopher J Schultz

Christopher J. Schultz, MD, FACR, FASTRO is a Professor of Radiation Oncology at the Medical College of Wisconsin, affiliated with the Clinical Cancer Center at Froedtert Hospital. His expertise spans radiation therapy innovations, particularly in brain tumors, head and neck cancers, and lymphoma. He focuses on advanced techniques like Gamma Knife radiosurgery, low-dose-rate irradiation, and MR-guided adaptive radiotherapy. His research emphasizes improving treatment efficacy through molecular analysis and dosimetric precision.

Education: MD from the Medical College of Wisconsin. Fellowships: FACR (American College of Radiologists), FASTRO (American Society for Radiation Oncology). His work integrates clinical practice with cutting-edge technologies, addressing challenges in radiation safety, treatment personalization, and health equity in academic oncology. He leads studies on tumor biology, radiation response biomarkers, and clinical guideline evolution.

• Key Research Areas: Radiation oncology innovations, radiobiology, MR-Linac systems, and clinical trial disparities analysis
• Notable Awards: FACR, FASTRO fellowships recognizing his contributions to radiology and radiation oncology
• Professional Contributions: Co-author on over 150 peer-reviewed articles, focusing on adaptive therapy, molecular profiling in gliomas, and radiation fractionation strategies

His lab develops cardiac atlases for MR-Linac safety, investigates pulsed low-dose radiation in glioblastoma, and evaluates systemic inequities in academic rank and compensation within radiation oncology. He collaborates on multi-institutional trials like NRG Oncology/RTOG studies and the MOMENTUM MR-Linac registry.